Skip to main content
Clinical Trials/NCT06486246
NCT06486246
Recruiting
Not Applicable

Geniculate Nerve Block Versus Adductor Canal Block for ACL Reconstruction Surgery

Hospital Clinic of Barcelona1 site in 1 country40 target enrollmentJune 26, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ACL Tear
Sponsor
Hospital Clinic of Barcelona
Enrollment
40
Locations
1
Primary Endpoint
Pain assessed by NRS at PACU
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Anterior cruciate ligament repair (ACL) surgery presents moderate to severe pain during the inmediate postoperative period and the first days after surgery. In addition, due to the interest of surgeons and patients for early reinstatement, the use of blockages that decrease the strength of the quadriceps is avoided. Therefore, in recent years, the adductor canal block (ACB) has been used for postoperative analgesia with variable results.

Genicular nerve block (GNB) has been used for pain management in patients with knee osteoarthritis and recently in knee arthroplasty surgery with results similar to the local anesthetic infiltration techniques by the surgeon (LIA). Considering their good results in these patients in addition to being a 100% sensitive block without risk of motor involvement.

The investigators proposed this experimental study to evaluate tha analgesic efficacy of the genicular nerve block (GNB) compared with the adductor canal block (ACB) for the Anterior cruciate ligament (ACL) repair surgery.

Detailed Description

Participants scheduled to undergo anterior cruciate ligament reconstruction under general anaesthesia will be allocated to two groups: Adductor canal block or Genicular nerve block- The adductor canal block will be performed by the anaesthesiologist under ultrasound guidance prior the surgery, after inducction , using 20 mLs Ropivacaine 0.2%. The genicular nerve block will be performed by the anaesthesiologist under ultrasound guidance prior the surgery, after inducction , using 20 mLs Ropivacaine 0.2% in total. Postoperative analgesia will include analgesia (Dexketoprofen 75 mg during first 24 hours), acetomiophen 1 gr every 8 hours and tramadol for rescue pain.

Registry
clinicaltrials.gov
Start Date
June 26, 2024
End Date
December 30, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Xavier Sala-Blanch

Principal investigator

Hospital Clinic of Barcelona

Eligibility Criteria

Inclusion Criteria

  • Patients from 18 to 50 years old scheduled to undergo anterior cruciate ligament reconstruction

Exclusion Criteria

  • peripheral neuropathy
  • pre-existing femoral neuropathy
  • diabetes mellitus
  • alcoholism
  • drug addiction
  • cancer with chemotherapy
  • chronic pain state
  • Negative of the patient to participate in the study.

Outcomes

Primary Outcomes

Pain assessed by NRS at PACU

Time Frame: up to 6 hours postoperative

Numerical raiting score (NRS) 0-10 (0= No pain; 10=maximum pain)

Opioid consumption at PACU

Time Frame: up to 6 hours postoperative

Metadone consumption in mg.

Secondary Outcomes

  • Pain score at home(up to 24 hours)
  • Quality of rest(First night)

Study Sites (1)

Loading locations...

Similar Trials